Help | RSS Feed



Hemispherx BioPharma, Inc. (AMEX:HEB) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Hemispherx BioPharma, Inc. (AMEX:HEB) seasonal charts above shows that a Buy Date of December 25 and a Sell Date of March 16 has resulted in a geometric average return of 7.86% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 37.85% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Hemispherx Biopharma Inc is a specialty pharmaceutical company. It is primarily engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore